Hemanth Prithvi, Nistala Pallavi, Nguyen Vy T, Eltit Jose M, Glennon Richard A, Dukat Małgorzata
Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, United States.
Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Front Pharmacol. 2023 Jan 24;14:1101290. doi: 10.3389/fphar.2023.1101290. eCollection 2023.
Certain 4-substituted analogs of 1-(2,5-dimethoxyphenyl)isopropylamine (2,5-DMA) are psychoactive classical hallucinogens or serotonergic psychedelic agents that function as human 5-HT (h5-HT) serotonin receptor agonists. Activation of a related receptor population, h5-HT receptors, has been demonstrated to result in adverse effects including cardiac valvulopathy. We previously published on the binding of several such agents at the two receptor subtypes. We hypothesized that, due to their structural similarity, the 5-HT and 5-HT receptor affinities of these agents might be related, and that QSAR studies might aid future studies. For a series of 13 compounds, it is demonstrated here that i) their published rat brain 5-HT receptor affinities are significantly correlated with their h5-HT (r = 0.942) and h5-HT (r = 0.916) affinities, ii) as with r5-HT receptor affinity, h5-HT affinity is correlated with the lipophilicity of the 4-position substituent (r = 0.798), iii) that eight of the ten compounds examined in functional (Ca mobilization in stable cell lines generated expressing the human 5-HT receptor using the Flp-In T-REx system) assays acted as h5-HT agonists (4-substituent = H, F, Br, I, OCHCH, NO, CH, CH) and two (hexyl and benzyl) as antagonists, iv) h5-HT affinity but not action was correlated with the lipophilicity of the 4-position substituent (r = 0.750; = 10). The findings suggest that h5-HT receptor affinity, and its relationship to substituent lipophilicity, might be approximated by rat and h5-HT affinity but cannot be used as a predictor of h5-HT agonist action of 2,5-DMA analogs. Furthermore, given that certain 2,5-DMA analogs are on the clandestine market, their potential to produce cardiac side effects following persistent or chronic use activation of h5-HT receptors should be considered.
1-(2,5-二甲氧基苯基)异丙胺(2,5-DMA)的某些4-取代类似物是具有精神活性的经典致幻剂或血清素能迷幻剂,它们作为人类5-羟色胺(h5-HT)血清素受体激动剂发挥作用。已证明激活相关受体群体h5-HT受体可导致包括心脏瓣膜病在内的不良反应。我们之前发表过几种此类药物与两种受体亚型的结合情况。我们推测,由于它们的结构相似性,这些药物的5-HT和5-HT受体亲和力可能相关,并且定量构效关系(QSAR)研究可能有助于未来的研究。对于一系列13种化合物,本文证明:i)它们已发表的大鼠脑5-HT受体亲和力与其h5-HT(r = 0.942)和h5-HT(r = 0.916)亲和力显著相关;ii)与r5-HT受体亲和力一样,h5-HT亲和力与4-位取代基的亲脂性相关(r = 0.798);iii)在功能测定(使用Flp-In T-REx系统在表达人类5-HT受体的稳定细胞系中进行钙动员)中检测的10种化合物中有8种作为h5-HT激动剂(4-取代基 = H、F、Br、I、OCHCH、NO、CH、CH),2种(己基和苄基)作为拮抗剂;iv)h5-HT亲和力而非作用与4-位取代基的亲脂性相关(r = 0.750; = 10)。这些发现表明,h5-HT受体亲和力及其与取代基亲脂性的关系可能可以通过大鼠和h5-HT亲和力来近似,但不能用作2,5-DMA类似物h5-HT激动剂作用的预测指标。此外,鉴于某些2,5-DMA类似物在非法市场上存在,应考虑它们在持续或长期使用后激活h5-HT受体而产生心脏副作用的可能性。